Creganna-Tactx Medical
REMEDI and Creganna-Tactx Medical are working on developing next generation solutions for delivery of stem cell therapies.
Creganna-Tactyx Medical creates, designs and builds products and technologies for medical device and lifescience companies. Based in Galway, Ireland and Marlborough, MA USA, Creganna-Tactyx Medical currently employs over 500 staff. It was ranked 36th in the 2007 Deloitte Technology Fast 50 list, a ranking of the 50 fastest growing technology companies in Ireland and the company has grown on average 24% per annum over the past 5 years. Creganna-Tactyx Medical is currently ranked among the Top 10 global outsourcing providers to the medical device industry.
Creganna-Tactyx Medical has specialist expertise in the design, development and manufacture of specialty needles and delivery device shafts used in catheter-based minimally invasive procedures. The company operates a dedicated Innovation Centre where innovative metal, polymer and injection moulded solutions for medical device applications are developed and commercialised. It is regarded as the world leader in hypotube-based device shafts.
“A partnership with REMEDI enables Creganna-Tactx Medical to participate in the next generation of medical therapies. The advent of convergent medicine is an exciting prospect for our industry – medical treatments that combine a number of medical and life science specialties. Through its cross-industry partnerships REMEDI is uniquely positioned to enable such convergence.”
Maura Leahy, Creganna
For more information, visit www.cregannatactx.com









